NCT01500616
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
- Locations
-
- Antwerp, Belgium
- Brussels, Belgium
- Charleroi, Belgium
- Ghent, Belgium
Clinical trial condition
Hepatitis
Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.
2,967 public trials
189 recruiting studies
Hepatitis trial results
Completed
A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon
NCT01531166
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- Sang Hoon Ahn Seoul, Seodaemun-gu, South Korea
NCT02761629
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Campinas, Brazil
- Florianópolis, Brazil
- Itajaí, Brazil
- Juiz de Fora, Brazil
NCT02726022
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Aigaleo - Attiki, Greece
- Athens, Greece
- Athens, Greece
- Athens, Greece
NCT02864199
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Birmingham, Alabama, United States
- Kansas City, Kansas, United States
- New Orleans, Louisiana, United States
- Kansas City, Missouri, United States
NCT01480284
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Aichi, Japan
- GSK Investigational Site Aichi, Japan
- GSK Investigational Site Chiba, Japan
- GSK Investigational Site Fukui, Japan
NCT01066819
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Birmingham, Alabama, United States
- Birmingham, Alabama, United States
- Birmingham, Alabama, United States
- Dothan, Alabama, United States
NCT01482403
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Littleton, Colorado, United States
- Chicago, Illinois, United States
- Shreveport, Louisiana, United States
- Detroit, Michigan, United States
NCT01457560
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
Not specified
NCT01457547
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Helsinki, Finland
- GSK Investigational Site Bari, Apulia, Italy
- GSK Investigational Site Galatina (LE), Apulia, Italy
- GSK Investigational Site Maglie (LE), Apulia, Italy